Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease

被引：0
|
作者：
Alan Zelicoff
机构：
[1] St. Louis University,Environmental and Occupational Health and Epidemiology, College for Public Health and Social Justice
来源：
Clinical Rheumatology | 2014年 / 33卷
关键词：
Public Health; Chronic Kidney Disease; Retrospective Study; Uric Acid; Kidney Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1837 / 1837
相关论文
共 50 条
  • [1] Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease
    Zelicoff, Alan
    CLINICAL RHEUMATOLOGY, 2014, 33 (12) : 1837 - 1837
  • [2] Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease
    Huang, Hsin Hsiang
    Chen, Yun-Yi
    Fang, Yu-Wei
    Liou, Hung-Hsiang
    Wang, Jing-Tong
    Tsai, Ming-Hsein
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [3] A COMPARATIVE EVALUATION OF THE HEALTH ECONOMIC OUTCOMES OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS WITH CHRONIC KIDNEY DISEASE
    Mitri, G.
    Wittbrodt, E. T.
    Turpin, R. S.
    Costa, L. A.
    Schulman, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 445 - 445
  • [4] EFFECT OF FEBUXOSTAT VERSUS ALLOPURINOL ON HYPERURICEMIA AND PROGRESSION OF CHRONIC KIDNEY DISEASE
    Nagaraju, Shankar Prasad
    Attur, Ravindra Prabhu
    Rangaswamy, Dharshan
    Rao, Indu
    Rao, Srikanth Prasad
    Kaza, Sindhu
    Shenoy, Srinivas
    Saraf, Karan
    Bhojaraja, Mohan
    Ramaswamy, Ashok
    Laxminarayana, Sindhura Lakshmi Koulmane
    Kosuru, Srinivas
    Parthasarathy, Rajeevalochana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [5] Febuxostat was Better than Allopurinol in Patients with Advanced Chronic Kidney Disease
    Hao, Zhen-Ye
    Qiao, Peng-Yan
    Wei, James Cheng-Chung
    Zhang, Li-Yun
    AMERICAN JOURNAL OF MEDICINE, 2025, 138 (04): : e68 - e68
  • [6] Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
    Tsuruta, Yuki
    Mochizuki, Toshio
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Takei, Takashi
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL RHEUMATOLOGY, 2014, 33 (11) : 1643 - 1648
  • [7] Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
    Yuki Tsuruta
    Toshio Mochizuki
    Takahito Moriyama
    Mitsuyo Itabashi
    Takashi Takei
    Ken Tsuchiya
    Kosaku Nitta
    Clinical Rheumatology, 2014, 33 : 1643 - 1648
  • [8] Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease
    Sakai, Yukinao
    Otsuka, Tomoyuki
    Ohno, Dai
    Murasawa, Tsuneo
    Sato, Naoki
    Tsuruoka, Shuichi
    RENAL FAILURE, 2014, 36 (02) : 225 - 231
  • [9] Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
    Kwak, Chae Hee
    Sohn, Minji
    Han, Nayoung
    Cho, Yoon-Sook
    Kim, Yon Su
    Oh, Jung Mi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (07) : 321 - 327
  • [10] Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression
    Park, Seokwoo
    Lee, Jung Pyo
    Kim, Dong Ki
    Kim, Yon Su
    Lim, Chun Soo
    PLOS ONE, 2022, 17 (02):
12345